Back to Search
Start Over
No Plasmodium falciparum Chloroquine Resistance Transporter and Artemisinin Resistance Mutations, Haiti.
- Source :
-
Emerging infectious diseases [Emerg Infect Dis] 2018 Nov; Vol. 24 (11), pp. 2124-2126. - Publication Year :
- 2018
-
Abstract
- We obtained 78 human blood samples from areas in Haiti with high transmission of malaria and found no drug resistance-associated mutations in Plasmodium falciparum chloroquine resistance transporter and Kelch 13 genes. We recommend maintaining chloroquine as the first-line drug for malaria in Haiti. Artemisinin-based therapy can be used as alternative therapy.
- Subjects :
- Adolescent
Adult
Aged
Child
Child, Preschool
Drug Resistance genetics
Haiti epidemiology
Humans
Infant
Malaria, Falciparum drug therapy
Malaria, Falciparum epidemiology
Middle Aged
Mutation
Plasmodium falciparum drug effects
Plasmodium falciparum isolation & purification
Surveys and Questionnaires
Young Adult
Antimalarials therapeutic use
Artemisinins therapeutic use
Chloroquine therapeutic use
Malaria, Falciparum parasitology
Membrane Transport Proteins genetics
Plasmodium falciparum genetics
Protozoan Proteins genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1080-6059
- Volume :
- 24
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Emerging infectious diseases
- Publication Type :
- Academic Journal
- Accession number :
- 30334724
- Full Text :
- https://doi.org/10.3201/eid2411.180738